A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol
A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol
Milagros Gonzalez-Rivera
1
, MD, MSc, PhD ;
Antoni C Picornell
2
, MPH, MSc, PhD ;
Enrique L Alvarez
2
, MSc ;
Miguel Martin
3
, MD, PhD
1
Gregorio Marañón Health Research Institute, Laboratory of Translational Oncology, Sequencing & Genotyping-Research Shared Resources, Gregorio Marañón General University Hospital, Madrid, Spain
2
Gregorio Marañón Health Research Institute, Department of Bioinformatics & Biostatistics, Gregorio Marañón General University Hospital, Madrid, Spain
3
Gregorio Marañón Health Research Institute, Medical Oncology Department, Gregorio Marañón General University Hospital, Madrid, Spain
Corresponding Author:
-
Milagros Gonzalez-Rivera, MD, MSc, PhD
-
Gregorio Marañón Health Research Institute
-
Laboratory of Translational Oncology, Sequencing & Genotyping-Research Shared Resources
-
Gregorio Marañón General University Hospital
-
Calle del Doctor Esquerdo 46
-
Madrid, 28007
-
Spain
-
Phone:
34 91 557 24 46
-
Fax: 34 91 586 83 94
-
Email: milagros.gonzalez@iisgm.com